The FDA approved the first gene therapy for some pediatric patients with Duchenne muscular dystrophy, a rare genetic condition that weakens the body’s muscles, on June 22.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st gene therapy for Duchenne muscular dystrophy
